logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

James B. Leverenz

cleveland clinic

98H-index
491Paper Count
4.2WCitation Count
Published Papers 177
Publication Date
logo
Patterns of cortical atrophy are associated with specific cognitive domains in patients with logopenic primary progressive aphasia
errJournal of Alzheimer’s Disease
IF0
err2025-11-17
err0
PREAI
errKatherine A Koenig; Xuemei Huang; Aaron Bonner-Jackson; James B Leverenz; Mark J Lowe; Jagan A Pillai
errShare
errSave
An Alternative Approach to the Finger-Tapping Test in Parkinsonian Patients: Finger to Crease Instead of Finger to Tip
errMovement Disorders Clinical Practice
IF2.7
err2025-11-05
err0
PREAI
errFahimeh H. Akhoundi MD; Yvette Bordelon MD, PhD; James Leverenz MD; Panteleimon Oikonomou MD; Irene Litvan MD
errShare
errSave
Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus
errJournal of Alzheimer’s Disease
IF0
err2025-09-25
err0
PREAI
errValerie Rico; Megan Zelinsky; Paul J Ford; James Leverenz; Jagan A Pillai; Justin B Miller; Kathryn Martinez; Alan J Lerner; Babak Tousi; Liana G Apostolova; Jalayne J Arias; Corey J Bolton; Alyssa A Brewer; Katie Bridgeman; Jeffrey M Burns; Tracy Butler; Kris Dierickx; Claire M Erickson; Cristina Festari; Fasihah Irfani Fitri; Nicole R Fowler; Seth A Gale; Chenlu Gao; Michael D Gallagher; Kim G Johnson; Jill K Morris; Corinna Porteri; Chenxi Qiu; Annalise Rahman-Filipiak; Zahra Rahemi; Edo Richard; Jolien Schaeverbeke; Yaakov Stern; Christine Suver; Shanna Trenaman; Marco Toccaceli Blasi; Rik Vandenberghe; Sarah Walter; Kristine Williams; Lauren R Sankary
errShare
errSave
Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease
errAlzheimer's & Dementia
IF11.1
err2025-09-02
err0
errOAAI
errPengyue Zhang; Chengsheng Mao; Anna Sun; Yuedi Yang; Yuan Hou; Zhimin Fu; Tousi Babak; James B. Leverenz; Andrew A. Pieper; Yuan Luo; Jeffrey Cummings; Feixiong Cheng
errShare
errSave
Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease
errALZHEIMERS & DEMENTIA
IF11.1
err2024-12-06
err0
PREAI
errXu, Jielin; Song, Wenqiang; Xu, Zhenxing; Danziger, Michael M.; Karavani, Ehud; Zang, Chengxi; Chen, Xin; Li, Yichen; Paz, Isabela M. Rivera; Gohel, Dhruv; Su, Chang; Zhou, Yadi; Hou, Yuan; Shimoni, Yishai; Pieper, Andrew A.; Hu, Jianying; Wang, Fei; Rosen-Zvi, Michal; Leverenz, James B.; Cummings, Jeffrey; Cheng, Feixiong
errShare
errSave
Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's disease
errJOURNAL OF ALZHEIMERS DISEASE
IF3.1
err2024-11-25
err1
PREAI
errXiyang, Yanbin; Gao, Ju; Ding, Mao; Ren, Xiaojia; Appleby, Brian S.; Leverenz, James B.; Miyagi, Masaru; Pillai, Jagan A.; Perry, George; Wang, Xinglong
errShare
errSave
Analytical and Clinical Verification of the Elecsys® Alzheimer's Disease Cerebrospinal Fluid Biomarkers pTau/Abeta42 and Total-Tau/Abeta42
errCLINICAL CHEMISTRY
IF6.3
err2024-10-02
err0
PREAI
errTroike, K.; Zilka, S.; Bekris, L. M.; Leverenz, J.; Khrestian, M.; DiFilippo, F. P.; Lowe, M.; Colon-Franco, J. M.
errShare
errSave
Long-Term Dementia Risk in Parkinson Disease
errNEUROLOGY
IF8.5
err2024-09-10
err0
errOAAI
errGallagher, Julia; Gochanour, Caroline; Caspell-Garcia, Chelsea; Dobkin, Roseanne D.; Aarsland, Dag; Alcalay, Roy N.; Barrett, Matthew J.; Chahine, Lana; Chen-Plotkin, Alice S.; Coffey, Christopher S.; Dahodwala, Nabila; Eberling, Jamie L.; Espay, Alberto J.; Leverenz, James B.; Litvan, Irene; Mamikonyan, Eugenia; Morley, James; Richard, Irene H.; Rosenthal, Liana; Siderowf, Andrew D.; Simuni, Tatyana; York, Michele K.; Willis, Allison W.; Xie, Sharon X.; Weintraub, Daniel
errShare
errSave
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies
errNEUROLOGY
IF8.5
err2024-08-13
err4
PREAI
errCoughlin, David G.; MacLeod, Karen R.; Middleton, John S.; Bozoki, Andrea C.; Galvin, James E.; Irwin, David J.; Lippa, Carol F.; Litvan, Irene; Lopez, Oscar L.; Berman, Sarah; Tsuang, Debby W.; Zabetian, Cyrus P.; Honig, Lawrence S.; Marder, Karen S.; Fleisher, Jori E.; Sabbagh, Marwan; Wint, Dylan; Taylor, Angela S.; Bekris, Lynn; Leverenz, James B.; Galasko, Douglas
errShare
errSave
Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data
errNPJ DIGITAL MEDICINE
IF15.1
err2024-07-09
err2
errOAAI
errSu, Chang; Hou, Yu; Xu, Jielin; Xu, Zhenxing; Zhou, Manqi; Ke, Alison; Li, Haoyang; Xu, Jie; Brendel, Matthew; Maasch, Jacqueline R. M. A.; Bai, Zilong; Zhang, Haotan; Zhu, Yingying; Cincotta, Molly C.; Shi, Xinghua; Henchcliffe, Claire; Leverenz, James B.; Cummings, Jeffrey; Okun, Michael S.; Bian, Jiang; Cheng, Feixiong; Wang, Fei
errShare
errSave
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients
errALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS
IF6.8
err2024-07-09
err4
errOAAI
errMatthews, Dawn C.; Kinney, Jefferson W.; Ritter, Aaron; Andrews, Randolph D.; Strom, Erin N. Toledano; Lukic, Ana S.; Koenig, Lauren N.; Revta, Carolyn; Fillit, Howard M.; Zhong, Kate; Tousi, Babak; Leverenz, James B.; Feldman, Howard H.; Cummings, Jeffrey
errShare
errSave
Lewy body pathologymodifies risk factors for cerebral amyloid angiopathywhen comorbidwith Alzheimer's disease pathology
errALZHEIMERS & DEMENTIA
IF11.1
err2024-02-14
err1
errOAAI
errPillai, Jagan A.; Bena, James; Tousi, Babak; Rothenberg, Kasia; Keene, C. Dirk; Leverenz, James B.
errShare
errSave
Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease
errCELL REPORTS MEDICINE
IF10.6
err2024-02-01
err7
errOAAI
errCheng, Feixiong; Wang, Fei; Tang, Jian; Zhou, Yadi; Fu, Zhimin; Zhang, Pengyue; Haines, Jonathan L.; Leverenz, James B.; Gan, Li; Hu, Jianying; Rosen-Zvi, Michal; Pieper, Andrew A.; Cummings, Jeffrey
errShare
errSave
Microglial immunometabolism endophenotypes contribute to sex difference in Alzheimer's disease
errALZHEIMERS & DEMENTIA
IF11.1
err2023-11-20
err4
errOAAI
errHou, Yuan; Caldwell, Jessica Z. K.; Lathia, Justin D.; Leverenz, James B.; Pieper, Andrew A.; Cummings, Jeffrey; Cheng, Feixiong
errShare
errSave
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium
errALZHEIMERS & DEMENTIA
IF11.1
err2023-09-23
err5
errOAAI
errJain, Lavanya; Khrestian, Maria; Formica, Shane; Tuason, Elizabeth D.; Pillai, Jagan A.; Rao, Stephen; Oguh, Odinachi; Lippa, Carol F.; Lopez, Oscar L.; Berman, Sarah B.; Tsuang, Debby W.; Zabetian, Cyrus P.; Irwin, David J.; Galasko, Douglas R.; Litvan, Irene; Marder, Karen S.; Honig, Lawrence S.; Fleisher, Jori E.; Galvin, James E.; Bozoki, Andrea C.; Taylor, Angela S.; Sabbagh, Marwan N.; Leverenz, James B.; Bekris, Lynn M.
errShare
errSave
123I-Ioflupane SPECT Striatal Binding Ratio Predicts Progression of Parkinsonism in a Dementia with Lewy Bodies Cohort
errNEUROLOGY
IF8.5
err2023-04-25
err0
PREAI
errMaly, Emily; Leverenz, James; DiFilippo, Frank
errShare
errSave
Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease
errALZHEIMERS RESEARCH & THERAPY
IF7.6
err2023-03-16
err28
errOAAI
errPillai, Jagan A.; Bena, James; Bekris, Lynn; Kodur, Nandan; Kasumov, Takhar B.; Leverenz, James B. R.; Kashyap, Sangeeta R.
errShare
errSave
Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care
errJOURNAL OF ALZHEIMERS DISEASE
IF3.1
err2023-02-20
err2
errOAAI
errRao, Stephen M.; Galioto, Rachel; Sokolowski, Megan; Pierce, Madelyn; Penn, Lisa; Sturtevant, Anna; Skugor, Blazenka; Anstead, Brent; Leverenz, James B.; Schindler, David; Blum, David; Alberts, Jay L.; Posk, Lori
errShare
errSave
Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel
errALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS
IF6.8
err2023-02-08
err4
errOAAI
errSabbagh, Marwan N.; Taylor, Angela; Galasko, Douglas; Galvin, James E.; Goldman, Jennifer G.; Leverenz, James B.; Poston, Kathleen L.; Boeve, Bradley F.; Irwin, David J.; Quinn, Joseph F.
errShare
errSave
Initial non-amnestic symptoms relate to faster rate of functional and cognitive decline compared to amnestic symptoms in neuropathologically confirmed dementias
errALZHEIMERS & DEMENTIA
IF11.1
err2023-01-17
err2
errOAAI
errPillai, Jagan A.; Bena, James; Maly, Emily F.; Leverenz, James B.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
John Q. Trojanowski
H-index: 255 · Papers: 1.8K
A
André G. Uitterlinden
H-index: 234 · Papers: 2.0K
D
Dennis W. Dickson
H-index: 218 · Papers: 2.3K
E
Eric Boerwinkle
H-index: 215 · Papers: 2.0K
K
Kaj Blennow
H-index: 214 · Papers: 3.6K
View more